NASDAQ : CDT
CDT Equity Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.077 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 86.59K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 21.89M | 22.11M | 12.04M | 5.17M | 3.05M | 2.89M |
| Research & Development | 3.36M | 5.05M | 3.38M | 90.00K | 37.00K | 28.00K |
| Operating Expenses | 25.25M | 27.16M | 15.42M | 5.26M | 3.09M | 2.92M |
| Operating Income | -25.25M | -27.16M | -15.42M | -5.26M | -3.09M | -2.92M |
| Interest Expense | -152.00K | -319.00K | -1.51M | -211.00K | ||
| Interest & Investment Income | 16.00K | 28.00K | 13.00K | 15.00K | ||
| Currency Exchange Gain (Loss) | -10.00K | 16.00K | -14.00K | 300.00K | -8.00K | |
| Other Non Operating Income (Expenses) | -2.65M | -2.84M | 144.00K | 4.62M | -1.67M | -655.00K |
| EBT Excluding Unusual Items | -28.20M | -30.28M | -16.78M | -535.00K | -4.76M | -3.58M |
| Gain (Loss) on Sale of Investments | -129.00K | -76.00K | ||||
| Legal Settlements | -9.59M | -9.59M | ||||
| Other Unusual Items | 649.00K | 649.00K | -706.00K | |||
| Pretax Income | -37.15M | -39.22M | -17.49M | -535.00K | -4.89M | -3.66M |
| Income Tax Expense | 314.00K | |||||
| Net Income | -37.15M | -39.22M | -17.80M | -535.00K | -4.89M | -3.66M |
| Net Income to Common | -37.15M | -39.22M | -17.80M | -535.00K | -4.89M | -3.66M |
| Free Cash Flow | -11.48M | -15.96M | -9.73M | -7.72M | -2.27M | -2.15M |
| EBITDA | -22.83M | -24.74M | -14.96M | |||
| D&A For EBITDA | 2.42M | 2.42M | 457.00K | |||
| EBIT | -25.25M | -27.16M | -15.42M | -5.26M | -3.09M | -2.92M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 747.00K | 1.51M | 554.00K | 4.23M | ||
| Cash & Short-Term Investments | 747.00K | 1.51M | 554.00K | 4.23M | ||
| Prepaid Expenses | 2.02M | 2.87M | 2.16M | 1.50M | ||
| Total Current Assets | 2.94M | 4.38M | 2.71M | 5.73M | ||
| Property, Plant & Equipment | 222.00K | 411.00K | 303.00K | |||
| Long-Term Deferred Charges | 5.00K | |||||
| Other Long-Term Assets | 702.00K | 860.00K | 1.18M | 1.49M | ||
| Total Assets | 126.71M | 5.65M | 4.19M | 7.22M | 5.00K | |
| Accounts Payable | 3.73M | 1.91M | 1.43M | 215.00K | ||
| Accrued Expenses | 802.00K | 9.79M | 1.96M | 601.00K | 2.58M | 2.23M |
| Current Portion of Long-Term Debt | 1.14M | 660.00K | 7.23M | 985.00K | 175.00K | |
| Current Portion of Leases | 45.00K | 115.00K | 119.00K | |||
| Other Current Liabilities | 17.64M | 338.00K | 1.42M | 6.00K | ||
| Total Current Liabilities | 23.35M | 12.82M | 10.74M | 1.80M | 4.18M | 2.23M |
| Long-Term Debt | 1.83M | 749.00K | ||||
| Long-Term Leases | 107.00K | |||||
| Long-Term Unearned Revenue | 4.08M | 2.96M | ||||
| Other Long-Term Liabilities | 264.00K | 138.00K | 5.88M | |||
| Total Liabilities | 23.61M | 12.82M | 10.99M | 7.68M | 10.09M | 5.94M |
| Common Stock | 7.00K | 6.00K | ||||
| Additional Paid-In Capital | 179.96M | 61.17M | 21.89M | 10.42M | ||
| Retained Earnings | -77.03M | -68.33M | -29.10M | -11.30M | -10.77M | -5.88M |
| Comprehensive Income & Other | 158.00K | -16.00K | 414.00K | 411.00K | 675.00K | -65.00K |
| Shareholders' Equity | 103.09M | -7.17M | -6.79M | -457.00K | -10.09M | -5.94M |
| Total Liabilities & Equity | 126.71M | 5.65M | 4.19M | 7.22M | 5.00K | |
| Total Debt | 1.18M | 775.00K | 7.46M | 985.00K | 2.01M | 749.00K |
| Net Cash (Debt) | -435.00K | 734.00K | -6.90M | 3.24M | -2.01M | -749.00K |
| Filing Date Shares Outstanding | 31.47K | 19.43K | 1.00 | |||
| Total Common Shares Outstanding | 25.24K | 1.00 | ||||
| Working Capital | -20.41M | -8.44M | -8.03M | 3.93M | -4.18M | -2.23M |
| Book Value Per Share | 4,084.02 | -457,000.00 | ||||
| Tangible Book Value | 103.09M | -7.17M | -6.79M | -457.00K | -10.09M | -5.94M |
| Tangible Book Value Per Share | 4,084.02 | -457,000.00 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -37.15M | -39.22M | -17.80M | -535.00K | -4.89M | -3.66M |
| Depreciation & Amortization | 2.42M | 2.42M | 457.00K | |||
| Other Amortization | 929.00K | |||||
| Loss (Gain) From Sale of Investments | -8.00K | 129.00K | 76.00K | |||
| Stock-Based Compensation | 5.90M | 5.36M | 1.83M | 199.00K | ||
| Other Operating Activities | 10.69M | 11.15M | 5.05M | -4.63M | 1.56M | 73.00K |
| Change in Accounts Payable | 2.50M | 434.00K | 1.23M | 215.00K | ||
| Change in Other Net Operating Assets | 4.00M | 4.29M | -1.37M | -2.73M | 596.00K | 1.36M |
| Operating Cash Flow | -11.48M | -15.55M | -9.68M | -7.72M | -2.27M | -2.15M |
| Capital Expenditures | -405.00K | -51.00K | ||||
| Investment in Securities | 8.00K | |||||
| Other Investing Activities | -403.00K | -403.00K | 725.00K | -183.00K | ||
| Investing Cash Flow | -403.00K | -808.00K | -43.00K | 725.00K | -183.00K | |
| Short-Term Debt Issued | 3.23M | 2.29M | ||||
| Long-Term Debt Issued | 1.11M | 688.00K | ||||
| Total Debt Issued | 1.80M | 3.23M | 2.29M | 1.11M | 688.00K | |
| Long-Term Debt Repaid | -2.17M | -776.00K | ||||
| Net Debt Issued (Repaid) | 1.31M | -2.17M | 2.45M | 2.29M | 1.11M | 688.00K |
| Issuance of Common Stock | 8.11M | 19.70M | 3.50M | 150.00K | 1.34M | 1.21M |
| Repurchase of Common Stock | -106.00K | |||||
| Other Financing Activities | 113.00K | 8.49M | ||||
| Financing Cash Flow | 9.41M | 17.42M | 6.07M | 10.93M | 2.45M | 1.90M |
| Foreign Exchange Rate Adjustments | -110.00K | -104.00K | -16.00K | 299.00K | 1.00K | 1.00K |
| Net Cash Flow | -2.58M | 955.00K | -3.67M | 4.23M | -252.00K | |
| Free Cash Flow | -11.48M | -15.96M | -9.73M | -7.72M | -2.27M | -2.15M |
| Levered Free Cash Flow | 19.62M | 5.22M | -5.49M | |||
| Unlevered Free Cash Flow | 19.71M | 5.42M | -5.48M | |||
| Cash Interest Paid | 11.00K | 80.00K | 124.00K | |||
| Change in Working Capital | 6.50M | 4.73M | -142.00K | -2.52M | 596.00K | 1.36M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 76.36K | 2.08M | 5.16M | 85.53B | 770.68M | |
| Enterprise Value | 511.36K | 117.00K | 7.67M | 85.52B | ||
| Last Close Price | 0.07 | 8,000.00 | 5,157,895.00 | 342,105,263.00 | 770,676,692.00 | |
| PB Ratio | 0.00 | -0.29 | -0.76 | -187,147.30 | -76.39 | |
| Debt / Equity Ratio | 0.01 | -0.11 | -1.10 | -2.15 | -0.20 | -0.13 |
| Net Debt / Equity Ratio | 0.00 | 0.10 | -1.02 | 7.10 | -0.20 | -0.13 |
| Net Debt / EBITDA Ratio | -0.02 | 0.03 | -0.46 | |||
| Net Debt / FCF Ratio | -0.04 | 0.05 | -0.71 | 0.42 | -0.89 | -0.35 |
| Quick Ratio | 0.04 | 0.12 | 0.05 | 2.35 | ||
| Current Ratio | 0.13 | 0.34 | 0.25 | 3.18 | ||
| Return on Assets (ROA) | -23.43% | -344.95% | -168.82% | -90.99% | ||
| Return on Capital Employed (ROCE) | -24.40% | 378.80% | 235.50% | -97.00% | 74.00% | 130.60% |
| Earnings Yield | -48,579.13% | -1,885.77% | -345.14% | -0.00% | -0.63% | |
| FCF Yield | -15,018.24% | -767.31% | -188.70% | -0.01% | -0.29% |